Recognition of the SARS-CoV-2 receptor binding domain by neutralizing antibodies

Immediately from the outset of the COVID-19 pandemic, researchers from diverse biomedical and biological disciplines have united to study the novel pandemic virus, SARS-CoV-2. The antibody response to SARS-CoV-2 has been a major focus of COVID-19 research due to its clinical relevance and importance...

Descripción completa

Detalles Bibliográficos
Autores principales: Yuan, Meng, Liu, Hejun, Wu, Nicholas C., Wilson, Ian A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7547570/
https://www.ncbi.nlm.nih.gov/pubmed/33069360
http://dx.doi.org/10.1016/j.bbrc.2020.10.012

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7547570/
https://www.ncbi.nlm.nih.gov/pubmed/33069360
http://dx.doi.org/10.1016/j.bbrc.2020.10.012

Ejemplares similares